OVARIAN ENDOMETRIOID TUMOR
Clinical trials for OVARIAN ENDOMETRIOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new OVARIAN ENDOMETRIOID TUMOR trials appear
Sign up with your email to follow new studies for OVARIAN ENDOMETRIOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug combo aims to outsmart recurrent ovarian cancer
Disease control OngoingThis early-phase trial tests whether adding an experimental drug called berzosertib to standard chemotherapy (carboplatin and gemcitabine) can better treat ovarian, peritoneal, or fallopian tube cancer that has returned and spread. The study involves 35 adults with platinum-sensi…
Matched conditions: OVARIAN ENDOMETRIOID TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug combo may outperform chemo for returning ovarian cancer
Disease control OngoingThis study tests whether olaparib (a targeted drug) alone or combined with cediranib (which blocks tumor blood vessels) works better than standard platinum chemo for women whose ovarian, fallopian tube, or peritoneal cancer has returned after initial treatment. About 579 particip…
Matched conditions: OVARIAN ENDOMETRIOID TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC